Drug manufacturers delayed reporting serious unexpected adverse events
Drug manufacturers did not report about 10% of serious and unexpected adverse events to the U.S. Food and Drug... More
Stevens-Johnson syndrome cases differ based on cause
Children with Stevens-Johnson syndrome associated with Mycoplasma pneumoniae were more likely to develop pneumonia, to... More
Dr. Richard Pazdur
Sonidegib, a hedgehog pathway inhibitor, has been approved for treating patients with locally advanced basal cell... More
Sylvia M. Burwell
As Medicare approaches its 50th anniversary next week, the federal program got some welcome financial news Wednesday:... More
AMA Town Hall: Doctors call for meaningful use delay
Stage 3 of meaningful use should be delayed until Medicare value-based care programs are developed. To move the... More
Dr. Christopher B. Zachary
VANCOUVER – Six developments – daylight photodynamic therapy, body sculpting, better laser treatments for tattoo... More
Don’t defer antiretrovirals in asymptomatic HIV patients
Clinicians should no longer defer initiating antiretroviral therapy in asymptomatic adults with newly diagnosed HIV... More
Nitric oxide nanoparticles prevent acne inflammation
Nitric oxide–releasing nanoparticles prevent Propionibacterium acnes–induced inflammation by clearing the organism and... More
David W. Hilgers
Sustaining an independent practice in today’s medical landscape isn’t easy, but it’s possible with the right care... More
GAO: Undercover agents effectively scammed healthcare.gov
Fictitious applicants were able to gain coverage from the federal health insurance marketplace and receive... More
Ericka L. Adler
Pay close attention to the outcomes of three cases winding their way through the courts this summer, legal experts... More
Dr. April Armstrong
VANCOUVER – Touch impairment is an important but largely unappreciated aspect of quality-of-life impairment in... More
GREGORY TWACHTMAN
There’s some good news and some bad news in this year’s Medicare Trustees’ report. The good news: The Part A trust fund will remain solvent until 2030, 13 years longer than previous report estimates. On the flip side, about a third of benefici... More »
 
AMY KARON
Drug manufacturers did not report about 10% of serious and unexpected adverse events to the U.S. Food and Drug Administration within the required time period, investigators reported online in JAMA Internal Medicine. Moreover, manufacturers were more... More »
 
TARA HAELLE
Children with Stevens-Johnson syndrome associated with Mycoplasma pneumoniae were more likely to develop pneumonia, to have fewer affected skin sites, and to have respiratory symptoms prior to the condition, a study found. “The spectrum of M. pneu... More »
 
ALICIA GALLEGOS
The government’s push toward value-based care aims to fix a broken reimbursement system and improve quality of care for patients. But the new payment models also bring new legal risks for physicians, experts and anti-fraud officials warn. “Novel... More »
 
ELIZABETH MECHCATIE
Sonidegib, a hedgehog pathway inhibitor, has been approved for treating patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation thera... More »
 
KATIE WAGNER LENNON
Using deferasirox to induce iron deficiency may improve the symptoms of congenital erythropoietic porphyria. The findings come from a study of a woman of Alaskan Native descent who was diagnosed as an infant with CEP and had compound heterozygosity ... More »
 
TANYA THOMAS, M.D.
I remember waking up with my left hand swollen, red, in excruciating pain, and difficult to move. For several months prior, I had been exhausted, achy, and stiff. As a relatively new mother attempting to manage the age-old balance of family life with... More »
 
ALEXIS R. OGDIE-BEATTY, M.D.
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) meeting was held in Stockholm this year on July 7 and 8. This year’s meeting was packed with updates regarding numerous projects, including, but not limited to, edu... More »
 
BRETT COLDIRON, M.D.
I have been a traveling road show for the last 2 years, explaining the value of dermatology to insurers. It is amazing how poorly understood we are by payers. Let me give you an example. Currently, dermatologists treat about 70% of all skin cancers... More »
 
JOSEPH S. EASTERN, M.D.
Revision of the Health Insurance Portability and Accountability Act (HIPAA) rules has prompted numerous questions about business associates (BAs) and business associate agreements (BAAs). Apparently there is confusion about exactly which businesses q... More »
 
NAISSAN WESLEY, M.D., AND LILY TALAKOUB, M.D.
We are so lucky to be part of a field of medicine where advances in patient treatment options continue to occur. Having been involved in the Kybella clinical trials, it is exciting and satisfactory to see a new successful aesthetic treatment come to ... More »
 
LESLIE S. BAUMANN, M.D.
The flavanone naringenin (5,7,4-trihydroxyflavanone) is known to exhibit anticarcinogenic, antioxidative, antiatherogenic, estrogenic, and immunomodulatory activity (Nutr. Cancer. 2012;64:714-24; J. Nutr. 2001;131:235-41; Life Sci. 2013;93:516-24). N... More »